Utility of MuSK antibodies in patients with myastenia gravis

Pichon-Riviere A, Augustovski F, Garcia Marti S, Bardach A, Galante J, Lopez A, Regueiro A, Glujovsky D, Aruj P, Calcagno J
Record ID 32009100166
Authors' methods: Review
Project Status: Completed
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Immunosuppressive Agents
  • Myasthenia Gravis
  • Receptor Protein-Tyrosine Kinases
  • Treatment Outcome
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.